Skip to main content
. Author manuscript; available in PMC: 2022 Feb 4.
Published in final edited form as: Int J Drug Policy. 2020 Jul 27;84:102875. doi: 10.1016/j.drugpo.2020.102875

Table 2.

Self-report HIV and HCV status, HIV and HCV testing uptake, and HIV and HCV test results stratified by opt-in and opt-out testing policy period.

Characteristic Total Sample (N = 1,059) Opt-In HIV/HCV Testing (N = 512) Opt-Out HIV/HCV Testing (N = 547) P-value
Self-report (SR) HIV positive 103 (10.4) 45 (9.4) 58 (11.4) 0.29
(N = 103) (N = 45) (N = 58)
Accepted HIV test 57 (55.3) 3 (6.7) 54 (93.1) <0.001
Tested HIV positive 49 (47.6) 2 (4.4) 47 (81.0) 0.32
Tested HIV negative 8 (7.8) 1 (2.2) 7 (12.1)
Self-report (SR) HIV negative or unknown 885 (89.6) 435 (90.6) 450 (88.6) 0.29
(N = 885) (N = 435) (N = 450)
Accepted HIV test 633 (71.5) 213 (49.0) 420 (93.3) <0.001
Tested HIV positive 7 (0.79) 1 (0.23) 6 (1.3) 0.28
Tested HIV negative 620 (70.1) 208 (47.8) 412 (91.6)
Self-report (SR) HCV positive 346 (37.9) 185 (42.1) 161 (34.1) 0.01
(N = 346) (N = 185) (N = 166)
Accepted HCV test 171 (49.4) 24 (13.0) 147 (91.3) <0.001
Tested HCV positive 144 (41.6) 21 (11.4) 123 (76.4) 0.49
Tested HCV negative 22 (6.4) 2 (1.1) 20 (12.4)
Self-report (SR) HCV negative or unknown 566 (62.1) 255 (57.9) 311 (65.9) 0.01
(N = 566) (N = 255) (N = 311)
Accepted HCV test 401 (70.9) 111 (43.5) 290 (93.3) <0.001
Tested HCV positive 76 (13.4) 27 (10.6) 49 (15.8) 0.07
Tested HCV negative 325 (57.4) 84 (32.9) 241 (77.5)

Note. Boldedp-value represent significance at alpha <0.05